Help is on the way for public health officials struggling to battle a new lethal drug concoction that combines fentanyl with horse tranquilizer Xylazine and sends users into a zombielike state.
This week, the House passed the Senate-amended version of HR 1734, the Testing, Rapid Analysis, and Narcotic Quality, or TRANQ, Research Act, marking a significant legislative action to address the latest drug trend that has begun ravaging every corner of the country, according to federal data.
The bill will now head to President Joe Biden’s desk where, if signed, it would direct the National Institute of Standards and Technology to increasingly focus on the science needed to detect, identify, and understand synthetic or manmade opioids like “tranq.”
Xylazine can extend the length of the opioid high and enhance feelings of euphoria. Combining xylazine with fentanyl can take an even greater toll on the human body than when taken alone. Fentanyl slows breathing and xylazine drops blood pressure, according to the National Institutes of Health.
Read more at Washingtonexaminer.com